Author

Ching‐Li Tseng

Taipei Medical UniversityORCID 0000-0001-9446-4030Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Ariel WidhibrataiD· 1 shared Che-Yi Chang· 1 shared Erh-Hsuan Hsieh· 1 shared Guei‐Sheung LiuiD· 1 shared Huai‐An CheniD· 1 shared I‐Chan LiniD· 1 shared Liling DelilaiD· 1 shared Thierry BurnoufiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Ariel WidhibrataORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Innovative platelet-derived extracellular vesicle drug delivery system for the treatment of corneal neovascularization

Guei‐Sheung Liu, Huai‐An Chen, Che-Yi Chang, Yin‐Ju Chen, Y.-Y. Wu, Ariel Widhibrata, Ya-Han Yang, Erh-Hsuan Hsieh, Liling Delila, I‐Chan Lin, Thierry Burnouf, Ching‐Li Tseng

This study evaluates platelet-derived extracellular vesicles (PEVs) loaded with kaempferol for treating corneal neovascularization, showing reduced vessel formation and inflammation in a mouse model.

Biomaterials · Feb 24, 2025Peer-reviewedBioengineering